Myopia Treatment Devices Market Report 2026

Myopia Treatment Devices Market Overview

• Myopia Treatment Devices market size has reached to $7.48 billion in 2025 • Expected to grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Prevalence Of Eye Diseases Fuels Growth In Market • Market Trend: Advanced Orthokeratology Platforms Accelerating Precision Myopia Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Myopia Treatment Devices Market?

Myopia treatment devices refer to various tools and technologies used to manage or correct myopia (nearsightedness). These devices utilize advanced technologies, such as reshaping the cornea with ortho-K lenses or using atropine drops, to slow the progression of myopia and improve vision without the need for constant corrective eyewear. The main product types of myopia treatment devices are eyeglasses, contact lenses, ortho-k lenses, phakic intraocular lenses, and excimer laser refractive surgery devices. Eyeglasses (or glasses) are wearable optical devices designed to correct vision problems or protect the eyes. The types of treatments include corrective lenses, laser eye surgery, and lens implant surgery for end use, such as hospitals and clinics, ophthalmic centers, retail stores, and online channels.

What Is The Myopia Treatment Devices Market Growth Forecast?

The myopia treatment devices market size is expected to see strong growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to AI-based eye diagnostics, expansion of ortho-k adoption, growth of laser vision correction, preventive pediatric eye care demand, personalized ophthalmic solutions. Major trends in the forecast period include myopia control lenses, early childhood vision correction, non-surgical vision management, customized vision therapy, minimally invasive laser treatments.

Global Myopia Treatment Devices Market Segmentation

1) By Product Type: Eye Glasses, Contact Lenses, Ortho-K Lenses, Phakic Intraocular Lenses, Excimer Laser Refractive Surgery Devices 2) By Treatment: Corrective Lenses, Laser Eye Surgery, Lens Implant Surgery 3) By End-Use: Hospitals And Clinics, Ophthalmic Centers, Retail stores, Online Channels Subsegments: 1) By Eye Glasses: Single Vision Glasses, Multifocal Glasses 2) By Contact Lenses: Soft Contact Lenses, Rigid Gas Permeable (RGP) Contact Lenses, Hybrid Contact Lenses 3) By Ortho-K Lenses: Overnight Ortho-K Lenses, Daytime Ortho-K Lenses 4) By Phakic Intraocular Lenses: Anterior Chamber Phakic IOLs, Posterior Chamber Phakic IOLs 5) By Excimer Laser Refractive Surgery Devices: LASIK (Laser-Assisted in Situ Keratomileusis) Devices, PRK (Photorefractive Keratectomy) Devices, SMILE (Small Incision Lenticule Extraction) Devices

What Is The Driver Of The Myopia Treatment Devices Market?

The increasing prevalence of eye diseases is expected to propel the growth of the myopia treatment devices market going forward. Eye diseases refer to a broad range of conditions or disorders that affect the structure or function of the eye, potentially impairing vision. The increasing prevalence of eye diseases is due to aging populations, rising screen time, lifestyle changes, and greater exposure to environmental pollutants. Myopia treatment devices help manage eye disease by slowing the progression of myopia, improving visual clarity, and reducing the risk of associated complications, ultimately offering a proactive approach to preserving eye health and enhancing the quality of life for those affected. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2024, 17.2% of Americans aged 40 and older, or about 20.5 million people, will have cataracts in at least one eye, with this number expected to rise to over 30 million by 2028. Therefore, the increasing prevalence of eye diseases is driving the growth of the myopia treatment devices industry.

Key Players In The Global Myopia Treatment Devices Market

Major companies operating in the myopia treatment devices market are EssilorLuxottica S.A., Carl Zeiss Meditec AG, Alcon Inc., Hoya Corporation, Bausch & Lomb Incorporated, CooperVision Inc., Johnson & Johnson Vision Care Inc., Topcon Corporation, Menicon Co. Ltd., STAAR Surgical Company, Paragon Vision Sciences Inc., Ziemer Ophthalmic Systems AG, Euclid Systems Corporation, Art Optical Contact Lens Inc., Schwind Eye Tech Solutions GmbH, Kubota Pharmaceutical Holdings Co Ltd., Visioneering Technologies Inc., Eyerising International, Nidek Co Ltd., Falco Linsen AG

Global Myopia Treatment Devices Market Trends and Insights

Major companies operating in the myopia treatment devices market are prioritizing innovation and technological advancements, such as cloud-based orthokeratology platforms, to strengthen their competitive position and meet the growing demand for efficient myopia-management solutions. Orthokeratology lenses are specially designed overnight lenses that temporarily reshape the cornea to correct myopia without the need for daytime eyewear. For instance, in March 2025, Bausch + Lomb Corporation, a Canada-based eye-health company, launched Arise, a new orthokeratology lens system in the United States that uses cloud-based intelligent design tools to deliver faster and more precise lens fitting. The Arise system includes FDA-cleared shaping lenses for overnight myopia reduction, helping reshape the cornea safely while the patient sleeps. This innovation aims to improve fitting efficiency for eye-care professionals, reduce chair time, and support clinicians in better managing pediatric myopia. The system also provides real-time data insights and design recommendations, enabling more accurate customization for young patients and enhancing treatment outcomes.

What Are Latest Mergers And Acquisitions In The Myopia Treatment Devices Market?

In January 2023, CooperVision Inc., a US-based manufacturer of contact lenses, acquired SynergEyes Inc. for an undisclosed amount. Through the acquisition, CooperVision aims to broaden its portfolio of specialty contact lenses, particularly enhancing its offerings for treating keratoconus and irregular corneas through the integration of SynergEyes' innovative hybrid lens technologies. SynergEyes Inc. is a US-based developer of hybrid contact lenses that involve myopia treatment devices.

Regional Outlook

North America was the largest region in the myopia treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Myopia Treatment Devices Market?

The myopia treatment devices market consists of sales of orthokeratology (ortho-k) lenses, myopia control contact lenses, atropine eye drops, smart glasses, and peripheral defocus lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.